3183 Stock Overview
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
WIN-Partners Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,177.00 |
| 52 Week High | JP¥1,344.00 |
| 52 Week Low | JP¥980.00 |
| Beta | 0.43 |
| 1 Month Change | -6.07% |
| 3 Month Change | -5.08% |
| 1 Year Change | 17.00% |
| 3 Year Change | 19.49% |
| 5 Year Change | -3.21% |
| Change since IPO | 206.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3183 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 1.3% | -0.3% | -1.0% |
| 1Y | 17.0% | 2.8% | 27.9% |
Return vs Industry: 3183 exceeded the JP Healthcare industry which returned 2.8% over the past year.
Return vs Market: 3183 underperformed the JP Market which returned 27.9% over the past year.
Price Volatility
| 3183 volatility | |
|---|---|
| 3183 Average Weekly Movement | 2.7% |
| Healthcare Industry Average Movement | 3.8% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 3183 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3183's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 609 | Hideumi Akizawa | www.win-partners.co.jp |
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic coils; and insulin pumps, as well as continuous glucose monitoring, and computed tomography equipment.
WIN-Partners Co., Ltd. Fundamentals Summary
| 3183 fundamental statistics | |
|---|---|
| Market cap | JP¥33.45b |
| Earnings (TTM) | JP¥1.69b |
| Revenue (TTM) | JP¥74.40b |
19.8x
P/E Ratio0.5x
P/S RatioIs 3183 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3183 income statement (TTM) | |
|---|---|
| Revenue | JP¥74.40b |
| Cost of Revenue | JP¥65.22b |
| Gross Profit | JP¥9.17b |
| Other Expenses | JP¥7.48b |
| Earnings | JP¥1.69b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 59.30 |
| Gross Margin | 12.33% |
| Net Profit Margin | 2.28% |
| Debt/Equity Ratio | 0% |
How did 3183 perform over the long term?
See historical performance and comparison